Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Navigator vs Standard Needle Injection for Hip

NCT02066844 is registered in ClinicalTrials.gov with Cartiva, Inc. as lead sponsor.

NCT NCT02066844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02066844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Navigator vs Standard Needle Injection for Hip
Lead sponsor
Cartiva, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2014
Completion date
August 31, 2014
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hip pain etiology unknown